Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
distributions. Project background The primary objective for the candidate is to design, implement, and use a coarse-grained representation for intrinsically disordered proteins (IDPs). In particular
-
different specializations, gain skills in computational technologies, and interact with world-class collaborators. Profile We expect from you: Recently obtained master degree in engineering or physics with
-
mathematics, computational sciences, or a related field. Additionally, you have prior programming experience and are fluent in English (oral and written). You show enthusiasm for conducting original research in
-
degree at the time of recruitment. Mobility rule: Applicants must not have resided or carried out their main activity (work, studies, etc.) in Switzerland for more than 12 months (in total) within
-
: Applicants must not have resided or carried out their main activity (work, studies, etc.) in Switzerland for more than 12 months (in total) within the three years immediately before recruitment. Workplace
-
projects and discussions. Teaching: Contribute to practicals and lectures assignments. Profile A Master's degree covering at least two of: physics, physical metallurgy, materials science. Background in solid
-
as possible. Applications are evaluated on a rolling basis until the position is filled. Profile Master's degree in Materials Science, Chemistry, Mechanical Engineering, Electrical Engineering, or
-
Center for AI Value, you will engage in groundbreaking research aimed at advancing the field of multimodal AI in management. Your primary focus will be conducting innovative research that leads
-
a multidisciplinary environment, driven by scientific curiosity and open to learning new topics. The Ph.D. candidate needs to be proficient in spoken and written English and have a Master's degree. S
-
28, 4058 Basel, and the Department of Chemistry at St. Johanns-Ring 19, 4056 Basel. Projects main focus: i) Targeting oncogenicity by orthosteric, allosteric or covalent inhibitors, generation of novel